Q3 2024 Blueprint Medicines Corp Earnings Call Transcript
Good morning. My name is Nadia, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines third-quarter 2024 financial results conference call. (Operator Instructions)
Jenna Cohen, you may begin your conference.
Thank you, Nadia. Good morning, everyone, and welcome to Blueprint Medicines third-quarter 2024 financial and operating results conference call.
This morning, we issued a press release which outlines the topics we plan to discuss today. You can access the press release, as well as the slides that we'll be reviewing today, by going to the Investors section of our website at www.blueprintmedicines.com.
Joining me today are Kate Haviland, Chief Executive Officer; Philina Lee, Chief Commercial Officer, Christy Rossi; Chief Operating Officer; and Mike Landsittel, Chief Financial Officer. Fouad Namouni, President,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |